HPC Market Watch

Arena Pharmaceuticals Soared On Rumor - NASDAQ:ARNA, GPRC, CLNT, SATC, AEZS
Las Vegas, NV -- (SBWIRE) -- 08/15/2012 -- Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) shares climbed 14.09% and closed at $8.26 in the previous trading session on renewed speculation that the company could be an acquisition target after getting FDA’s approval for its new diet drug lorcaserin, also known as Belviq in June. Read the full press release at http://www.sbwire.com/press-releases/arena-pharmaceuticals-soared-on-rumor-nasdaqarna-gprc-clnt-satc-aezs-158953.htm
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here

Share This